H.C. Wainwright Initiates Avidity Biosciences(RNA.US) With Buy Rating, Announces Target Price $72

Futu NewsDec 21 02:31 · Ratings

This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

BenzingaDec 20 22:52

What 8 Analyst Ratings Have To Say About Avidity Biosciences

BenzingaDec 20 20:00 · Ratings

Avidity Biosciences Initiated at Buy by HC Wainwright & Co.

Dow JonesDec 20 19:45 · Ratings

Avidity Biosciences Price Target Announced at $72.00/Share by HC Wainwright & Co.

Dow JonesDec 20 19:45 · Ratings

Avidity Biosciences Insider Sold Shares Worth $831,605, According to a Recent SEC Filing

MT NewswiresDec 19 05:53